The effect of treatment with Campath-1H in patients with autoimmune cytopenias.
We describe 21 patients with severe and life-threatening autoimmune cytopenias resistant to standard immunosuppression who were treated with the monoclonal antibody Campath-1H. Four patients had autoimmune neutropenia, four had autoimmune haemolytic anaemia, four had pure red cell aplasia, one had i...
Main Authors: | Willis, F, Marsh, J, Bevan, D, Killick, S, Lucas, G, Griffiths, R, Ouwehand, W, Hale, G, Waldmann, H, Gordon-Smith, E |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2001
|
Títulos similares
-
Sustained remission of severe resistant autoimmune neutropenia with Campath-1H.
por: Killick, S, et al.
Publicado: (1997) -
CAMPATH-1 MOAB IN THE TREATMENT OF REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA (ATP)
por: Lim, S, et al.
Publicado: (1993) -
CAMPATH-1H in inflammatory arthritis.
por: Watts, R, et al.
Publicado: (1993) -
CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
por: Lim, S, et al.
Publicado: (1993) -
TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
por: Watts, R, et al.
Publicado: (1992)